Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation: Interest of continuous glucose monitoring

Diabetes Care

Volumn 25, Issue 12, 2002, Pages 2256-2262

  Kessler, Laurence ^a   Passemard, Raphael ^a   Oberholzer, Jose ^b   Benhamou, Pierre Yves ^c   Bucher, Pascal ^b   Toso, Christian ^b   Meyer, Pierre ^a   Penfornis, Alfred ^d   Badet, Lionel ^e   Wolf, Philippe ^a   Colin, Cyrille ^e   Morel, Philippe ^b   Pinget, Michel ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITY HOSPITAL   (Switzerland)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF BESANÇON   (France)

^e NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEVICE; DRUG DELIVERY SYSTEM; DRUG INFUSION; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; IMPLANTATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INTERMETHOD COMPARISON; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MONITORING; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; POSTOPERATIVE PERIOD; RECORDING; SUBCUTANEOUS TISSUE; TIME; TREATMENT OUTCOME; ADULT; BLOOD; CIRCADIAN RHYTHM; CLINICAL TRIAL; FEMALE; FOLLOW UP; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY;

ADULT; BLOOD GLUCOSE; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIA; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PANCREAS TRANSPLANTATION; TIME FACTORS;

EID: 0141964474     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.12.2256     Document Type: Article

References (27)

1. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. Gautier JF, Beressi JP, Leblanc H, Vexiau P, Passa P: Are the implications of the Diabetes Control and Complications Trial (DCCT) feasible in daily clinical practice? Diabete Metab 22:415-419, 1996
3. Pinget M, Jeandidier N: Long term safety and efficacy of intraperitoneal insulin infusion by means of implantable pumps. Horm Metab Res 30:475-486, 1999
4. Selam JL: Implatable insulin pumps. Lancet 354:178-179, 1999
5. Kessler L, Tritschler S, Bohbot A, Sigrist S, Belcourt A, Pinget M: Macrophage activation in type 1 diabetic patients with catheter obstruction during peritoneal insulin delivery with an implantable pump. Diabetes Care 24:302-307, 2001
6. Tyden G, Bolinder J, Solders G, Brattstrom C, Tibell A, Groth CG: Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation. Transplantation 67:645-648, 1999
7. Smets YF, Westendorp RG, van der Pijl JW, de Charro FT, Ringers J, de Fijter JW: Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure. Lancet 353:1915-1919, 1999
8. Farney AC, Cho E, Schweitzer EJ: Simultaneous cadaver pancreas living-donors kidney transplantation: a new approach for the type 1 diabetic uremic patients. Ann Surg 232:696-703, 2000
9. Humar A, Kandaswamy R, Granger D: Decrease surgical risks of pancreas transplantation in the modern era. Ann Surg 231:269-275, 2000
10. Kessler L, Wiesel ML, Lutun E, Boudjema K, Moulin B, Cazenave JP, Wolf Ph, Pinget M: Possible involvement of von Willebrand factor in the pancreatic graft thrombosis after pancreas-kidney transplantation: a retrospective study. Clin Transpl 2:37-42, 1998
11. Brendel MD, Hering BJ, Schultz AO, Bretzel RG: Adult islet allografts in type 1 diabetic recipients. In International Islet Transplant Registry Newsletter. Giessen, Germany, Third Medical Department, Center of Internal Medicine, University Hospital Giessen, 2001, no. 8, p. 9-17
12. Secchi A, Socci C, Maffi P, Taglietti MV, Bertuzzi F, De Nittio P, Piemonti L, Scopi L, Di Carlo V, Pozza G: Islet transplantation in IDDM patients. Diabetologia 40:225-231, 1997
13. Luzi L, Perseghin G, Brendel MD, Terruzzi I, Battezzati A, Eckhard M, Brandhorst D, Brandhorst H, Friemann S, Socci C, Di CarloV, Piceni Sereni L, Benedini S, Secchi A, Pozza G, Bretzel RG: Metabolic effects of restoring partial beta cell function after islet allotransplantation in type 1 diabetic patients. Diabetes 50:277-282, 2001
14. Benhamou PY, Oberholzer J, Toso C, Kessler L, Penfornis A, Bayle F, Thivolet C, Martin X, Ris F, Badet L, Colin C, Morel P: Human islet transplantation network for the treatment of type 1 diabetes: first data from Swiss-French GRAGIL consortium (1999-2000). Diabetologia 44:859-864, 2001
15. Ryan EA, Lakey JRT, Rajotte RV, Korbutt GS, Kin T, Imes S, Rabinovitch A, Elliot JF, Bigman D, Kneteman NM, Warnock GL, Larsen I, Shapiro AMJ: Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 50:710-719, 2001
16. Bolinder J, Hagstrom-Toft E, Ungerstedt U, Arner P: Self-monitoring of blood glucose in type 1 diabetic patients: comparison with continuous microdialysis measurements of glucose in subcutaneous adipose tissue during ordinary life conditions. Diabetes Care 20:64-70, 1997
17. Mastrototaro J: The MiniMed continuous glucose monitoring system (CGMS). J Pediatr Endocrinol Metab 12:751-758, 1999
18. Bode BW, Gross TM, Thornton KR: Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 46:183-190, 1999
19. Chase HP, Kim LM, Owen SL, Mac Kenzie TA, Klingensmith GJ, Murtfeldt R, Garg SK: Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics 107:222-226, 2002
20. Rebrin K, Steil GM, Van Antwerp WP: Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. Am J Physiol 277:561-571, 1999
21. Oberholzer J, Triponez F, Mage R, Andereggen E, Bulher L, Cretin N, Fournier B, Goumaz C, Lou J, Philippe J, Morel P: Human islet transplantation: lessons from 13 autologus and 13 allogeneic transplantations. Transplantation 69:1115-1123, 2000
22. Schmidtke DW, Freeland AC, Heler A, Bonnecaze RT: Measurement and modelling of the transient difference between blood and subcutaneous glucose concentrations in the rat after injection of insulin. Proc Natl Acad Sci U S A 95:294-299, 1998
23. Zung A, Zadik Z: Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics 109:347, 2002
24. Melki V, Hanaire-Broutin H: Indication of CGMS (continuous glucose monitoring system) in the functional investigations of adult type 1 diabetic patients. Diabete Metab 27:618-623, 2001
25. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF: Mean amplitude of glycaemic excursions, a measure of diabetic instability. Diabetes 19:644-655, 1970
26. Selam JL: How to measure glycaemic instability. Diabete Metab 26:148-151, 2000
27. Redmon JB, Teuscher AU, Robertson RP: Hypoglycemia after pancreas transplantation. Diabetes Care 21:1944-1950, 1998